A study on infectivity of asymptomatic SARS-CoV-2 carriers – PubMed

A study on infectivity of asymptomatic SARS-CoV-2 carriers


Free PMC article


Background: An ongoing outbreak of coronavirus disease 2019 (COVID-19) has spread around the world. It is debatable whether asymptomatic COVID-19 virus carriers are contagious. We report here a case of the asymptomatic patient and present clinical characteristics of 455 contacts, which aims to study the infectivity of asymptomatic carriers.

Material and methods: 455 contacts who were exposed to the asymptomatic COVID-19 virus carrier became the subjects of our research. They were divided into three groups: 35 patients, 196 family members and 224 hospital staffs. We extracted their epidemiological information, clinical records, auxiliary examination results and therapeutic schedules.

Results: The median contact time for patients was four days and that for family members was five days. Cardiovascular disease accounted for 25% among original diseases of patients. Apart from hospital staffs, both patients and family members were isolated medically. During the quarantine, seven patients plus one family member appeared new respiratory symptoms, where fever was the most common one. The blood counts in most contacts were within a normal range. All CT images showed no sign of COVID-19 infection. No severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections was detected in 455 contacts by nucleic acid test.

Conclusion: In summary, all the 455 contacts were excluded from SARS-CoV-2 infection and we conclude that the infectivity of some asymptomatic SARS-CoV-2 carriers might be weak.

Keywords: Asymptomatic carrier; Contacts; Infectivity; SARS-CoV-2.

Conflict of interest statement

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.


Fig. 1

Similar articles

See all similar articles

Cited by 6 articles

See all “Cited by” articles


    1. Lescure F.X., Bouadma L., Nguyen D. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect. Dis. 2020;20 doi: 10.1016/S1473-3099(20)30200-0. Published Online March 27 2020. – DOIPMCPubMed
    1. Adalja A.A., Toner E., Inglesby T.V. JAMA; 2020. Priorities for the US Health Community Responding to COVID-19. Published Online March 03 2020. Available at: – DOIPubMed
    1. McCloskey B., Zumla A., Ippolito G. Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma. Lancet. 2020;395:1096–1099. doi: 10.1016/S0140-6736(20)30681-4. – DOIPMCPubMed
    1. World Health Organization . 2020. Coronavirus Disease (COVID-19) Outbreak.https://www.who.int/emergencies/diseases/novel-coronavirus-2019 Available at:
    1. Lu R., Zhao X., Li J. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565–574. doi: 10.1016/S0140-6736(20)30251-8. – DOIPMCPubMed

Publication types

MeSH terms


Supplementary concepts